(0.00%) 5 187.67 points
(0.44%) 39 056 points
(-0.18%) 16 303 points
(1.07%) $79.22
(-1.13%) $2.18
(-0.35%) $2 316.10
(0.08%) $27.57
(-0.36%) $984.80
(0.09%) $0.930
(0.04%) $10.90
(0.10%) $0.800
(0.33%) $91.75
-6.44% $ 0.0900
Live Chart Being Loaded With Signals
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally...
Stats | |
---|---|
Volumen de hoy | 94 115.00 |
Volumen promedio | 26 624.00 |
Capitalización de mercado | 10.24M |
EPS | $0 ( 2024-01-02 ) |
Próxima fecha de ganancias | ( $0 ) 2024-06-26 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.00 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2014-01-31 | Doroudian Ahmad | Sell | 0 | Common Shares |
2014-01-31 | Doroudian Ahmad | Buy | 0 | Common Shares |
2011-01-31 | Doroudian Ahmad | Sell | 0 | Common Shares |
2011-01-31 | Doroudian Ahmad | Buy | 0 | Common Shares |
2010-05-25 | Doroudian Ahmad | Buy | 800 000 | Stock Options |
INSIDER POWER |
---|
0.00 |
Last 6 transactions |
Buy: 1 300 000 | Sell: 0 |
BetterLife Pharma Inc. Correlación
10 Correlaciones Más Positivas |
---|
10 Correlaciones Más Negativas |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
BetterLife Pharma Inc. Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-18 435.00 (0.00 %) |
EPS: | $-0.100 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-18 435.00 (0.00 %) |
EPS: | $-0.100 |
FY | 2022 |
Ingresos: | $26.93B |
Beneficio Bruto: | $26.93B (100.00 %) |
EPS: | $-0.160 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-1.340 |
Financial Reports:
No articles found.
BetterLife Pharma Inc.
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's pipeline products include BETR-001 for the treatment of major depressive disorder, treatment resistance depression, cluster headaches, and post-traumatic stress disorder; and BETR-002 to treat benzodiazepine dependency, anxiety, and spasticity. It is also developing MM-003 for treatment of COVID-19 and other respiratory viral infections; MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and AP-002 for the treatment of cancer. BetterLife Pharma Inc. has a research agreement with the University of California San Diego for preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. The company was formerly known as Pivot Pharmaceuticals Inc. and changed its name to BetterLife Pharma Inc. in December 2019. BetterLife Pharma Inc. was incorporated in 2002 and is headquartered in Vancouver, Canada.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico